Evidence map›Paper›PMID 38915828›Full record

ArticleMicrosystems & nanoengineering2024

An acoustofluidic device for the automated separation of platelet-reduced plasma from whole blood.

Zhehan Ma, Jianping Xia, Neil Upreti, Emeraghi David, Joseph Rufo, Yuyang Gu, Kaichun Yang, Shujie Yang, Xiangchen Xu, Jean Kwun and 2 more

Abstract read
In one paragraph

Article in Microsystems & nanoengineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Isolation Techniques of Micro/Nano-Scaled Species for Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhehan Ma *Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC USA.
Jianping Xia *Thomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC USA.ORCID 0000-0001-9902-0228
Neil UpretiDepartment of Biomedical Engineering, Duke University, Durham, NC USA.ORCID 0000-0002-0751-8174
Emeraghi DavidDepartment of Pediatrics, Duke University, Durham, NC USA.
Joseph RufoThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC USA.ORCID 0000-0001-7408-2393
Yuyang GuThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC USA.ORCID 0000-0002-6545-2521
Kaichun YangThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC USA.
Shujie YangThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC USA.
Xiangchen XuThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC USA.
Jean KwunDuke Transplant Center, Department of Surgery, Duke University School of Medicine, Durham, NC USA.
Eileen ChambersDepartment of Pediatrics, Duke University, Durham, NC USA.
Tony Jun HuangThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC USA.

Funding

Development of a novel acoustofluidic device for targeted antibody removal in pediatric organ transplant rejectionR21HD102790 · NICHD · DUKE UNIVERSITY · PI CHAMBERS, EILEEN TSAI · 2021 to 2022
$443k
NICHD NIH HHS R21 HD102790
6 · The paper itself

Abstract

Separating plasma from whole blood is an important sample processing technique required for fundamental biomedical research, medical diagnostics, and therapeutic applications. Traditional protocols for plasma isolation require multiple centrifugation steps or multiunit microfluidic processing to sequentially remove large red blood cells (RBCs) and white blood cells (WBCs), followed by the removal of small platelets. Here, we present an acoustofluidic platform capable of efficiently removing RBCs, WBCs, and platelets from whole blood in a single step. By leveraging differences in the acoustic impedances of fluids, our device generates significantly greater forces on suspended particles than conventional microfluidic approaches, enabling the removal of both large blood cells and smaller platelets in a single unit. As a result, undiluted human whole blood can be processed by our device to remove both blood cells and platelets (>90%) at low voltages (25 Vpp). The ability to successfully remove blood cells and platelets from plasma without altering the properties of the proteins and antibodies present creates numerous potential applications for our platform in biomedical research, as well as plasma-based diagnostics and therapeutics. Furthermore, the microfluidic nature of our device offers advantages such as portability, cost efficiency, and the ability to process small-volume samples.

Indexed as

EngineeringPhysics

Identifiers

PMID38915828
PMCPMC11194281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.